Literature DB >> 22333316

Modeling caffeine concentrations with the Stanford Caffeine Questionnaire: preliminary evidence for an interaction of chronotype with the effects of caffeine on sleep.

Philip Nova1, Beatriz Hernandez, Adam S Ptolemy, Jamie M Zeitzer.   

Abstract

OBJECTIVE: To examine the validity of a novel caffeine intake questionnaire and to examine the effects of caffeine on sleep in college students.
METHODS: One-week, ad libitum behavior of 50 university students (28 female, 22 male; aged 20.9 ± 1.78 years) was examined with sleep logs, wrist actigraphy, and a novel daily questionnaire assessing caffeine intake at different times of day. Saliva samples were collected for caffeine assessment (questionnaire validation) and DNA extraction, and for analysis of a single nucleotide polymorphism in the adenosine receptor 2A (ADORA2A) gene.
RESULTS: The caffeine questionnaire was able to accurately predict salivary concentrations of caffeine (R(2) = 0.41, P<0.001). Estimations of integrated salivary caffeine concentration during sleep were correlated with wake after sleep onset (WASO) most strongly in morning-type individuals (R(2) = 0.49; P<0.001, ANOVA), less so in intermediate chronotypes (R(2) = 0.16; P<0.001, ANOVA), and not significantly in evening-types (R(2) = 0.00098; P = 0.13, ANOVA). Using multivariate modeling methods we found that the ADORA2A genotype did not moderate the effects of caffeine on WASO, but did independently alter WASO such that those with the CC genotype had nearly three-times as much WASO as those with CT or TT.
CONCLUSIONS: Our questionnaire was able to accurately predict salivary caffeine concentrations and helped to describe a novel relationship between the effects of caffeine on sleep and genotype and chronotype. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22333316     DOI: 10.1016/j.sleep.2011.11.011

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  7 in total

1.  Eveningness Chronotype, Daytime Sleepiness, Caffeine Consumption, and Use of Other Stimulants Among Peruvian University Students.

Authors:  Anjalene Whittier; Sixto Sanchez; Benjamín Castañeda; Elena Sanchez; Bizu Gelaye; David Yanez; Michelle A Williams
Journal:  J Caffeine Res       Date:  2014-03-01

2.  Sleep quality and sleep patterns in relation to consumption of energy drinks, caffeinated beverages, and other stimulants among Thai college students.

Authors:  Vitool Lohsoonthorn; Hazar Khidir; Gardenia Casillas; Somrat Lertmaharit; Mahlet G Tadesse; Wipawan C Pensuksan; Thanapoom Rattananupong; Bizu Gelaye; Michelle A Williams
Journal:  Sleep Breath       Date:  2012-12-14       Impact factor: 2.816

3.  Local Use-Dependent Sleep in Wakefulness Links Performance Errors to Learning.

Authors:  Angelica Quercia; Filippo Zappasodi; Giorgia Committeri; Michele Ferrara
Journal:  Front Hum Neurosci       Date:  2018-04-03       Impact factor: 3.169

4.  A Pilot Study Providing Evidence for a Relationship between a Composite Lifestyle Score and Risk of Higher Carotid Intima-Media Thickness: Is There a Link to Oxidative Stress?

Authors:  Neda Seyedsadjadi; Jade Berg; Ayse A Bilgin; Ross Grant
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

5.  A comparison of sleep, depressive symptoms, and parental perceptions between U.S. and Taiwan adolescents with self-reported sleep problems.

Authors:  Ya-Ting Yang; Katherine A Kaplan; Jamie M Zeitzer
Journal:  Sleep Adv       Date:  2020-09-14

Review 6.  Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives.

Authors:  Carolin Franziska Reichert; Tom Deboer; Hans-Peter Landolt
Journal:  J Sleep Res       Date:  2022-05-16       Impact factor: 5.296

7.  Significant relationships between a simple marker of redox balance and lifestyle behaviours; Relevance to the Framingham risk score.

Authors:  Neda Seyedsadjadi; Jade Berg; Ayse A Bilgin; Chin Tung; Ross Grant
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.